PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.97%
Positive revenue growth while ACB.TO is negative. John Neff might see a notable competitive edge here.
-9.53%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-37.46%
Negative EBIT growth while ACB.TO is at 48.32%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-37.46%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
111.86%
Net income growth above 1.5x ACB.TO's 46.09%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
116.82%
EPS growth above 1.5x ACB.TO's 53.67%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
116.82%
Diluted EPS growth above 1.5x ACB.TO's 53.67%. David Dodd would see if there's a robust moat protecting these shareholder gains.
68.21%
Share count expansion well above ACB.TO's 16.29%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
68.21%
Diluted share count expanding well above ACB.TO's 15.40%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
9996.05%
OCF growth above 1.5x ACB.TO's 9.34%. David Dodd would confirm a clear edge in underlying cash generation.
105.91%
FCF growth above 1.5x ACB.TO's 9.90%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
759.81%
5Y revenue/share CAGR at 50-75% of ACB.TO's 1350.47%. Martin Whitman would worry about a lagging mid-term growth trajectory.
558.89%
Positive 3Y CAGR while ACB.TO is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
1314.74%
Positive long-term OCF/share growth while ACB.TO is negative. John Neff would see a structural advantage in sustained cash generation.
272.75%
Positive OCF/share growth while ACB.TO is negative. John Neff might see a comparative advantage in operational cash viability.
153.74%
3Y OCF/share CAGR above 1.5x ACB.TO's 56.10%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1568.31%
Positive 10Y CAGR while ACB.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
378.70%
Positive 5Y CAGR while ACB.TO is negative. John Neff might view this as a strong mid-term relative advantage.
445.35%
Positive short-term CAGR while ACB.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
10037.12%
10Y equity/share CAGR above 1.5x ACB.TO's 948.84%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
2200.76%
5Y equity/share CAGR above 1.5x ACB.TO's 993.78%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
109.26%
Positive short-term equity growth while ACB.TO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.83%
Our AR growth while ACB.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-4.14%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
173.68%
Asset growth above 1.5x ACB.TO's 0.18%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
115.95%
Positive BV/share change while ACB.TO is negative. John Neff sees a clear edge over a competitor losing equity.
28.79%
We have some new debt while ACB.TO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
188.72%
R&D growth drastically higher vs. ACB.TO's 39.72%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-20.02%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.